opportunities in Asia-Pacific
Biomedical Strategy Consultants Pte
Ltd is a strategic consulting and investment advisory firm serving the
global medical devices, diagnostics, pharmaceutical
and biotechnology industries with particular focus on opportunities in
The Asia market is huge and
growing. With a 3.5 billion population, some 60% of the world total,
Asia Pacific’s healthcare markets offer significant scope for growth
compared with the established markets of the U.S. and Europe.
The Asian pharmaceutical market was
worth some US$159 billion in 2008. Medical technology in Asia-Pacific
accounted for approximately US$81 billion of a global market valued at
US$315 billion in 2008.
There are many ways for companies
to tap into this vast business potential but key to success is to
understand the nature of the market. Asia is not a coherent whole. Each
country has its distinct way of doing business in terms
of regulations, practices, sales channels and approach to
decision-making and relationship building. What succeeds in one country
may fail in another. Local knowledge is essential.
We are strategically located in Singapore,
with offices in Malaysia, Tokyo, Mumbai, Beijing,
Sydney and additional partners and associates in
other Asian nations and Europe and North America.
With over 100 years’ combined experience from the biomedical
in Asia-Pacific, Biomedical Strategy Consultants is ideally positioned
to assist Asian, European and North America based healthcare companies
to fully exploit the opportunities in the region.
We provide services in
international business development to healthcare companies, ranging from
seed, early stage and emerging growth companies to divisions of Fortune
500 corporations. We also provide industry insights and advice to
venture capital firms and other private equity investors. Our services
are based on our
industry and geographic track record, expertise and knowledge for
companies to achieve sustained profitable growth through opportunities
in sales, partnerships and funding.